Search Results - "Kooy, M Marwijk"

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years by Cornelissen, J J, Versluis, J, Passweg, J R, van Putten, W L J, Manz, M G, Maertens, J, Beverloo, H B, Valk, P J M, van Marwijk Kooy, M, Wijermans, P W, Schaafsma, M R, Biemond, B J, Vekemans, M-C, Breems, D A, Verdonck, L F, Fey, M F, Jongen-Lavrencic, M, Janssen, J J W M, Huls, G, Kuball, J, Pabst, T, Graux, C, Schouten, H C, Gratwohl, A, Vellenga, E, Ossenkoppele, G, Löwenberg, B

“…The preferred type of post-remission therapy (PRT) in patients with acute myeloid leukemia (AML) in first complete remission (CR1) is a subject of continued…”
Get full text

Intensified alemtuzumab–CHOP therapy for peripheral T-cell lymphoma by Kluin-Nelemans, H.C., van Marwijk Kooy, M., Lugtenburg, P.J., van Putten, W.L.J., Luten, M., Oudejans, J., van Imhoff, G.W.

“…The prognosis of T-cell lymphoma is poor. To explore the addition of the monoclonal antibody alemtuzumab, we studied the efficacy and tolerability of an…”
Get full text

Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON by Daenen, S, van der Holt, B, Dekker, A W, Willemze, R, Rijneveld, A W, Biemond, B J, Muus, P, van de Loosdrecht, A A, Schouten, H C, van Marwijk Kooy, M, Breems, D A, Demuynck, H, Maertens, J, Wijermans, P W, Wittebol, S, de Klerk, E W, Cornelissen, J J

Get full text

A randomized clinical trial on the effectiveness of an intervention to treat psychological distress and improve quality of life after autologous stem cell transplantation by Braamse, Annemarie M. J., van Meijel, B., Visser, O. J., Boenink, A. D., Cuijpers, P., Eeltink, C. E., Hoogendoorn, A. W., van Marwijk Kooy, M., van Oppen, P., Huijgens, P. C., Beekman, A. T. F., Dekker, J.

“…Psychological distress contributes to impaired quality of life in hematological cancer patients. Stepped care treatment, in which patients start with the least…”
Get full text

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial by Verelst, Silvia G. R., Termorshuizen, F., Uyl-de Groot, C. A., Schaafsma, M. R., Ammerlaan, A. H. M., Wittebol, S., Sinnige, H. A. M., Zweegman, S., van Marwijk Kooy, M., van der Griend, R., Lokhorst, H. M., Sonneveld, P., Wijermans, P. W.

“…Thalidomide with melphalan/prednisone (MPT) was defined as standard treatment in elderly patients with multiple myeloma (MM) based on five randomized trials…”
Get full text

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma by VAN IMHOFF, G. W, VAN DER HOLT, B, RAEMAEKERS, J. M. M, SONNEVELD, P, MEULENDIJKS, L. A. M. H, KLUIN, P. M, KLUIN-NELEMANS, H. C, VERDONCK, L. F, MACKENZIE, M. A, OSSENKOPPELE, G. J, WIJERMANS, P. W, KRAMER, M. H. H, VAN 'T VEER, M. B, SCHOUTEN, H. C, VAN MARWIJK KOOY, M, VAN OERS, M. H. J

“…The feasibility and efficacy of up-front high-dose sequential chemotherapy followed by autologous stem cell transplantation (ASCT) in previously untreated…”
Get full text

Molecular Minimal Residual Disease in Acute Myeloid Leukemia by Jongen-Lavrencic, Mojca, Grob, Tim, Hanekamp, Diana, Kavelaars, François G, al Hinai, Adil, Zeilemaker, Annelieke, Erpelinck-Verschueren, Claudia A.J, Gradowska, Patrycja L, Meijer, Rosa, Cloos, Jacqueline, Biemond, Bart J, Graux, Carlos, van Marwijk Kooy, Marinus, Manz, Markus G, Pabst, Thomas, Passweg, Jakob R, Havelange, Violaine, Ossenkoppele, Gert J, Sanders, Mathijs A, Schuurhuis, Gerrit J, Löwenberg, Bob, Valk, Peter J.M

“…Among patients with acute myeloid leukemia, gene sequencing during remission revealed that persistent mutations in genes associated with clonal hematopoiesis…”
Get full text

Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts by van der Helm, L.H, Veeger, N.J.G.M, Kooy, M. van Marwijk, Beeker, A, de Weerdt, O, de Groot, M, Alhan, C, Hoogendoorn, M, Laterveer, L, van de Loosdrecht, A.A, Koedam, J, Vellenga, E, Huls, G

“…Abstract The efficacy of azacitidine has been demonstrated in acute myeloid leukemia (AML) patients with 20–30% bone marrow (BM) blasts, but limited data is…”
Get full text

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial by Goldschmidt, H, Lokhorst, H M, Mai, E K, van der Holt, B, Blau, I W, Zweegman, S, Weisel, K C, Vellenga, E, Pfreundschuh, M, Kersten, M J, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, M S, Broijl, A, Lindemann, H W, Bos, G M J, Brossart, P, van Marwijk Kooy, M, Ypma, P, Duehrsen, U, Schaafsma, R M, Bertsch, U, Hielscher, T, Jarari, Le, Salwender, H J, Sonneveld, P

“…The Dutch-Belgian Cooperative Trial Group for Hematology Oncology Group-65/German-speaking Myeloma Multicenter Group-HD4 (HOVON-65/GMMG-HD4) phase III trial…”
Get full text

Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study by De Wildt-Eggen, J., Nauta, S., Schrijver, J.G., Van Marwijk Kooy, M., Bins, M., Van Prooijen, H.C.

“…BACKGROUND: Reactions after platelet transfusions are rather common and frequently are caused by plasma constituents. In recent developments, the preparation…”
Get full text

Failure of CHOP with rituximab for lymphomatoid granulomatosis by OOSTING-LENSTRA, S. F, VAN MARWIJK KOOY, M

“…We present a 66-year-old male patient with pulmonary lymphomatoid granulomatosis. The patient had progressive disease after three courses of CHoP and rituximab…”
Get full text

P406: ENHANCED SIGNIFICANCE OF FLT3‐ITD RESIDUAL DISEASE DETECTION ON TREATMENT OUTCOME IN ACUTE MYELOID LEUKEMIA by Grob, T., Sanders, M., Vonk, C., Kavelaars, F., Rijken, M., Hanekamp, D., Gradowska, P., Cloos, J., Fløisand, Y., Marwijk Kooy, M. V., Manz, M., Ossenkoppele, G., Tick, L., Havelange, V., Löwenberg, B., Jongen‐Lavrencic, M., Valk, P.

Get full text

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma by LOKHORST, H. M, SONNEVELD, P, VETH, G, VERDONCK, L. F, WIJERMANS, P. W, CORNELISSEN, J. J, JOOSTEN, P, VAN MARWIJK KOOY, M, MEINEMA, J, NIEUWENHUIS, H. K, VAN OERS, M. H. J, RICHEL, D. J, SEGEREN, C. N

“…We performed a phase II study to test the efficacy and feasibility of induction therapy with vincristine, adriamycin and dexamethasone (VAD) and…”
Get full text

UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species by van Marwijk Kooy, M, Akkerman, J W, van Asbeck, S, Borghuis, L, van Prooijen, H C

“…Previous studies have shown that ultraviolet B (UVB) radiation causes platelet aggregation by exposing fibrinogen binding sites via activation of an…”
Get more information

A patient with multiple myeloma and respiratory insufficiency due to accumulation of paraprotein in the alveolar space by Meijer, W G, Van Marwijk Kooy, M, Laddé, B E

“…We describe a patient with multiple myeloma and respiratory insufficiency. Autopsy revealed accumulation of IgG-kappa paraprotein in the alveolar space. The…”
Get more information

Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism by Leclercq, M. G. L., Kruip, M. J. H. A., Mac Gillavry, M. R., Van Marwijk Kooy, M., Büller, H. R.

Get full text

Evaluation of a new UVB source for irradiation of platelet concentrates by van Prooijen, H C, van Marwijk Kooy, M, van Weelden, H, Aarts-Riemens, M I, Borghuis, L, Akkerman, J W

“…The application of ultraviolet B (UVB) radiation has been proposed as a new technology to decrease immunogenicity of leucocytes in platelet transfusions. UV…”
Get more information

Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients by Huls, Gerwin, Chitu, Dana A., Havelange, Violaine, Jongen-Lavrencic, Mojca, van de Loosdrecht, Arjan A., Biemond, Bart J., Sinnige, Harm, Hodossy, Beata, Graux, Carlos, Kooy, Rien van Marwijk, de Weerdt, Okke, Breems, Dimitri, Klein, Saskia, Kuball, Jürgen, Deeren, Dries, Terpstra, Wim, Vekemans, Marie-Christiane, Ossenkoppele, Gert J., Vellenga, Edo, Löwenberg, Bob

“…The prevention of relapse is the major therapeutic challenge in older patients with acute myeloid leukemia (AML) who have obtained a complete remission (CR) on…”
Get full text

A woman with a swollen, erythematous and tender thigh by Nauta, S, van Marwijk Kooy, M, van der Ven, A J A M

Get full text

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial by Scheid, Christof, Sonneveld, Pieter, Schmidt-Wolf, Ingo G H, van der Holt, Bronno, el Jarari, Laila, Bertsch, Uta, Salwender, Hans, Zweegman, Sonja, Blau, Igor Wolfgang, Vellenga, Edo, Weisel, Katja, Pfreundschuh, Michael, Jie, Kon-Siong, Neben, Kai, van de Velde, Helgi, Duehrsen, Ulrich, Schaafsma, M Ron, Lindemann, Walter, Kersten, Marie José, Peter, Norma, Hänel, Mathias, Croockewit, Sandra, Martin, Hans, Wittebol, Shulamiet, Bos, Gerard Mj, van Marwijk-Kooy, Marinus, Wijermans, Pierre, Goldschmidt, Hartmut, Lokhorst, Henk M

“…Renal impairment is frequent in patients with multiple myeloma and is correlated with an inferior prognosis. This analysis evaluates the prognostic role of…”
Get full text